Background {#Sec1}
==========

Polymyxin E, also known as colistin is a multicomponent polypeptide antibiotic, which belongs to the group of polymyxin \[[@CR1]\]. Polymyxin E was discovered in the 1940s; yet, later on, it was abandoned in clinical practice due to its increased nephrotoxicity. However, due to the increase of multidrug resistance (MDR) in Gram-negative bacteria, especially in the ESKAPE pathogens (*Enterococcus faecium*, *Staphylococcus aureus*, *Klebsiella pneumoniae*, *Acinetobacter baumannii*, *Pseudomonas aeruginosa*, and *Enterobacter* species), colistin has been applied in clinical practice for the last few years as the last resort treatment option \[[@CR2], [@CR3]\]. Currently, colistin resistance is considered a serious problem, due to a lack of alternative antibiotics \[[@CR4], [@CR5]\]. As for now, rapid identification of colistin resistance is considered essential for the effective control of MDR Gram-negative bacteria infection.

Broth microdilution (BMD) is the only reference method that has been recommended by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) for the detection of minimum inhibitory concentrations (MICs) of colistin \[[@CR6], [@CR7]\]. Nevertheless, colistin antimicrobial susceptibility testing is very challenging to perform \[[@CR8], [@CR9]\]. For example, the operational steps of BMD are complex and time-consuming, making it unsuitable for clinical use \[[@CR10]\]. Clinical microbiology laboratories are especially affected by the lack of an accurate, fast and easy-to-conduct method to test the colistin susceptibility \[[@CR11]--[@CR13]\]. Therefore, it is of great significance for clinical anti-infective treatment to develop and promote new, convenient, economical, rapid and accurate colistin sensitivity detection method.

In 2016, Nordmann et al developed the Rapid Polymyxins NP test for *Enterobacteriaceae spp* \[[@CR14]\]. The method can be used to detect bacteria that can grow, metabolize glucose, and produce acid in the presence of polymyxin such as polymyxin B or colistin through color changes of PH indicators. However, one of the significant limitations when using this approach is that it cannot be applied for non-fermentative bacteria such as *A. baumannii* and *P. aeruginosa*. More recently, Lescat et al have developed a rapid resazurin-mucoid susceptibility test method called Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test, which can quickly detect the sensitivity of colistin for both *Enterobacteriaceae spp* and non-fermentative bacteria within 4 h \[[@CR15]\]. The method is mainly based on detection of the strain viability by observing the color change of resazurin (an active colorant) from blue to purple or pink in the presence of colistin (3.75 mg/L).

In this study, we analyzed the performance of the Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test in the detection of colistin susceptibility in 253 nonduplicate clinical Gram-negative isolates aiming to provide a basis for the popularization and application of a new method for rapid screening of colistin-resistant common clinical Gram-negative bacteria.

Results {#Sec2}
=======

The colistin MICs of the 253 Gram-negative isolates ranged from ≤0.06 to ≥32 mg/L. BMD results were used as a standard, and 53 colistin-resistant strains and 198 colistin susceptible strains were correctly detected by the Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test. Very major errors (VME) and major errors (ME) corresponded to false-susceptible and false-resistant results, respectively \[[@CR16]\]. There were only two ME in *A. baumannii*; details are shown in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}. The specificity of *A. baumannii* was 96%; while the sensitivity and specificity of the Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test to *P. aeruginosa*, *K. pneumoniae* and *E. coli* were 100% (Table [3](#Tab3){ref-type="table"}). Table 1Colistin MICs obtained by broth microdilution and results of the Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP testIsolateSpeciesResistant PhenotypeMIC (mg/L)Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP TestResultDiscrepancies with BMD MIC colistin resultBM1539*A. baumannii*R8PositiveNoBM1579*A. baumannii*R4PositiveNoBM1595*A. baumannii*R4PositiveNoBM2349*A. baumannii*R4PositiveNoBM2370*A. baumannii*R16PositiveNoBM2412*A. baumannii*R4PositiveNoBM2431*A. baumannii*R8PositiveNoBM2622*A. baumannii*R8PositiveNoTL1671*P. aeruginosa*R4PositiveNoTL1722*P. aeruginosa*R4PositiveNoTL1736*P. aeruginosa*R≥32PositiveNoTL1744*P. aeruginosa*R4PositiveNoTL2204*P. aeruginosa*R4PositiveNoTL2294*P. aeruginosa*R4PositiveNoTL2314*P. aeruginosa*R≥32PositiveNoTL2917*P. aeruginosa*R4PositiveNoTL2967*P. aeruginosa*R4PositiveNoTL3008*P. aeruginosa*R16PositiveNoTL3086*P. aeruginosa*R≥32PositiveNoFK20*K. pneumoniae*R≥32PositiveNoFK26*K. pneumoniae*R≥32PositiveNoFK150*K. pneumoniae*R≥32PositiveNoFK169*K. pneumoniae*R≥32PositiveNoFK171*K. pneumoniae*R≥32PositiveNoFK591*K. pneumoniae*R≥32PositiveNoFK610*K. pneumoniae*R≥32PositiveNoFK1342*K. pneumoniae*R≥32PositiveNoFK1913*K. pneumoniae*R≥32PositiveNoFK1986*K. pneumoniae*R8PositiveNoFK2066*K. pneumoniae*R≥32PositiveNoFK2166*K. pneumoniae*R≥32PositiveNoFK2778*K. pneumoniae*R≥32PositiveNoFK2911*K. pneumoniae*R≥32PositiveNoFK3789*K. pneumoniae*R≥32PositiveNoFK3810*K. pneumoniae*R≥32PositiveNoFK3994*K. pneumoniae*R≥32PositiveNoFK6556*K. pneumoniae*R32PositiveNoFK6663*K. pneumoniae*R32PositiveNoFK6696*K. pneumoniae*R16PositiveNoDC90*E. coli*R8PositiveNoDC2562*E. coli*R8PositiveNoDC3411*E. coli*R4PositiveNoDC3539*E. coli*R16PositiveNoDC3599*E. coli*R8PositiveNoDC3658*E. coli*R8PositiveNoDC3737*E. coli*R8PositiveNoDC3802*E. coli*R4PositiveNoDC3806*E. coli*R8PositiveNoDC3846*E. coli*R16PositiveNoDC4887*E. coli*R8PositiveNoDC5262*E. coli*R8PositiveNoDC5286*E. coli*R8PositiveNoDC7333*E. coli*R4PositiveNoBM1505*A. baumannii*S0.125NegativeNoBM1506*A. baumannii*S0.5NegativeNoBM1507*A. baumannii*S0.06NegativeNoBM1508*A. baumannii*S0.125NegativeNoBM1509*A. baumannii*S0.125NegativeNoBM1510*A. baumannii*S0.125NegativeNoBM1511*A. baumannii*S0.125NegativeNoBM1512*A. baumannii*S0.25NegativeNoBM1513*A. baumannii*S0.125NegativeNoBM1514*A. baumannii*S0.125NegativeNoBM4151*A. baumannii*S0.25NegativeNoBM4152*A. baumannii*S0.06NegativeNoBM4153*A. baumannii*S0.03NegativeNoBM4154*A. baumannii*S0.125NegativeNoBM4155*A. baumannii*S0.125NegativeNoBM4156*A. baumannii*S0.125NegativeNoBM4158*A. baumannii*S0.125NegativeNoBM4159*A. baumannii*S0.125NegativeNoBM4160*A. baumannii*S0.5NegativeNoBM4161*A. baumannii*S0.125NegativeNoBM4162*A. baumannii*S0.06NegativeNoBM4163*A. baumannii*S0.06NegativeNoBM4164*A. baumannii*S0.06NegativeNoBM4165*A. baumannii*S0.06NegativeNoBM4166*A. baumannii*S0.125NegativeNoBM4167*A. baumannii*S0.125NegativeNoBM4168*A. baumannii*S0.25NegativeNoBM4169*A. baumannii*S0.5NegativeNoBM4170*A. baumannii*S0.125NegativeNoBM4171*A. baumannii*S0.06NegativeNoBM4172*A. baumannii*S≤0.06NegativeNoBM4173*A. baumannii*S0.06NegativeNoBM4174*A. baumannii*S0.06NegativeNoBM4175*A. baumannii*S2NegativeNoBM4176*A. baumannii*S0.06NegativeNoBM4177*A. baumannii*S0.06NegativeNoBM4178*A. baumannii*S0.06NegativeNoBM4179*A. baumannii*S0.25NegativeNoBM4180*A. baumannii*S0.06NegativeNoBM4181*A. baumannii*S0.125NegativeNoBM4182*A. baumannii*S0.25NegativeNoBM4183*A. baumannii*S1NegativeNoBM4184*A. baumannii*S1PositiveYes, MEBM4185*A. baumannii*S1NegativeNoBM4186*A. baumannii*S1NegativeNoBM4187*A. baumannii*S0.125NegativeNoBM4188*A. baumannii*S0.5PositiveYes, MEBM4189*A. baumannii*S0.5NegativeNoBM4190*A. baumannii*S0.125NegativeNoBM4191*A. baumannii*S0.5NegativeNoTL2916*P. aeruginosa*S0.125NegativeNoTL2915*P. aeruginosa*S≤0.06NegativeNoTL2914*P. aeruginosa*S0.125NegativeNoTL2913*P. aeruginosa*S0.125NegativeNoTL2911*P. aeruginosa*S0.125NegativeNoTL2910*P. aeruginosa*S0.25NegativeNoTL2908*P. aeruginosa*S0.125NegativeNoTL2907*P. aeruginosa*S0.5NegativeNoTL2906*P. aeruginosa*S0.125NegativeNoTL2905*P. aeruginosa*S0.125NegativeNoTL2904*P. aeruginosa*S0.125NegativeNoTL2901*P. aeruginosa*S0.125NegativeNoTL2899*P. aeruginosa*S0.125NegativeNoTL2898*P. aeruginosa*S0.125NegativeNoTL2897*P. aeruginosa*S0.125NegativeNoTL2895*P. aeruginosa*S0.125NegativeNoTL2893*P. aeruginosa*S≤0.06NegativeNoTL2892*P. aeruginosa*S0.125NegativeNoTL2891*P. aeruginosa*S0.06NegativeNoTL2890*P. aeruginosa*S0.25NegativeNoTL2889*P. aeruginosa*S0.5NegativeNoTL2886*P. aeruginosa*S0.5NegativeNoTL2885*P. aeruginosa*S0.25NegativeNoTL2884*P. aeruginosa*S0.25NegativeNoTL2883*P. aeruginosa*S0.5NegativeNoTL2882*P. aeruginosa*S0.25NegativeNoTL2881*P. aeruginosa*S0.25NegativeNoTL2879*P. aeruginosa*S0.25NegativeNoTL2878*P. aeruginosa*S0.25NegativeNoTL2877*P. aeruginosa*S0.25NegativeNoTL2875*P. aeruginosa*S0.25NegativeNoTL2874*P. aeruginosa*S0.25NegativeNoTL2873*P. aeruginosa*S1NegativeNoTL2872*P. aeruginosa*S0.125NegativeNoTL2871*P. aeruginosa*S0.25NegativeNoTL2870*P. aeruginosa*S2NegativeNoTL2869*P. aeruginosa*S0.125NegativeNoTL2868*P. aeruginosa*S0.125NegativeNoTL2867*P. aeruginosa*S0.125NegativeNoTL2866*P. aeruginosa*S0.125NegativeNoTL2865*P. aeruginosa*S0.125NegativeNoTL2864*P. aeruginosa*S0.25NegativeNoTL2863*P. aeruginosa*S≤0.06NegativeNoTL2862*P. aeruginosa*S0.125NegativeNoTL2861*P. aeruginosa*S0.25NegativeNoTL2858*P. aeruginosa*S0.25NegativeNoTL2857*P. aeruginosa*S0.25NegativeNoTL2856*P. aeruginosa*S0.125NegativeNoTL2855*P. aeruginosa*S0.25NegativeNoTL2854*P. aeruginosa*S0.125NegativeNoFK3640*K. pneumoniae*S≤0.06NegativeNoFK3642*K. pneumoniae*S≤0.06NegativeNoFK3646*K. pneumoniae*S≤0.06NegativeNoFK3660*K. pneumoniae*S≤0.06NegativeNoFK3671*K. pneumoniae*S0.125NegativeNoFK3686*K. pneumoniae*S0.5NegativeNoFK3695*K. pneumoniae*S≤0.06NegativeNoFK3696*K. pneumoniae*S≤0.06NegativeNoFK3703*K. pneumoniae*S≤0.06NegativeNoFK3712*K. pneumoniae*S≤0.06NegativeNoFK3719*K. pneumoniae*S≤0.06NegativeNoFK3721*K. pneumoniae*S≤0.06NegativeNoFK3724*K. pneumoniae*S1NegativeNoFK3727*K. pneumoniae*S0.5NegativeNoFK3730*K. pneumoniae*S≤0.06NegativeNoFK3732*K. pneumoniae*S0.25NegativeNoFK3738*K. pneumoniae*S≤0.06NegativeNoFK3739*K. pneumoniae*S0.125NegativeNoFK3740*K. pneumoniae*S≤0.06NegativeNoFK3741*K. pneumoniae*S≤0.06NegativeNoFK3745*K. pneumoniae*S0.5NegativeNoFK3746*K. pneumoniae*S1NegativeNoFK3749*K. pneumoniae*S≤0.06NegativeNoFK3758*K. pneumoniae*S≤0.06NegativeNoFK3764*K. pneumoniae*S≤0.06NegativeNoFK3767*K. pneumoniae*S≤0.06NegativeNoFK3771*K. pneumoniae*S0.5NegativeNoFK3784*K. pneumoniae*S≤0.06NegativeNoFK3800*K. pneumoniae*S0.5NegativeNoFK3803*K. pneumoniae*S0.25NegativeNoFK3813*K. pneumoniae*S≤0.06NegativeNoFK3817*K. pneumoniae*S≤0.06NegativeNoFK3824*K. pneumoniae*S0.06NegativeNoFK3830*K. pneumoniae*S≤0.06NegativeNoFK3831*K. pneumoniae*S≤0.06NegativeNoFK3838*K. pneumoniae*S0.5NegativeNoFK3844*K. pneumoniae*S0.125NegativeNoFK3853*K. pneumoniae*S0.125NegativeNoFK3878*K. pneumoniae*S0.25NegativeNoFK3882*K. pneumoniae*S≤0.06NegativeNoFK3891*K. pneumoniae*S≤0.06NegativeNoFK3927*K. pneumoniae*S0.125NegativeNoFK3938*K. pneumoniae*S0.5NegativeNoFK3943*K. pneumoniae*S0.06NegativeNoFK3946*K. pneumoniae*S0.5NegativeNoFK3989*K. pneumoniae*S≤0.06NegativeNoFK3990*K. pneumoniae*S1NegativeNoFK3996*K. pneumoniae*S0.125NegativeNoFK3999*K. pneumoniae*S≤0.06NegativeNoFK4002*K. pneumoniae*S≤0.06NegativeNoDC8640*E. coli*S0.25NegativeNoDC8641*E. coli*S≤0.06NegativeNoDC8642*E. coli*S0.125NegativeNoDC8643*E. coli*S0.125NegativeNoDC8644*E. coli*S0.5NegativeNoDC8645*E. coli*S≤0.06NegativeNoDC8646*E. coli*S≤0.06NegativeNoDC8647*E. coli*S≤0.06NegativeNoDC8648*E. coli*S≤0.06NegativeNoDC8649*E. coli*S0.125NegativeNoDC8650*E. coli*S0.06NegativeNoDC8651*E. coli*S0.06NegativeNoDC8652*E. coli*S0.125NegativeNoDC8653*E. coli*S0.06NegativeNoDC8654*E. coli*S0.06NegativeNoDC8655*E. coli*S0.06NegativeNoDC8656*E. coli*S0.125NegativeNoDC8657*E. coli*S≤0.06NegativeNoDC8658*E. coli*S0.06NegativeNoDC8659*E. coli*S≤0.06NegativeNoDC8660*E. coli*S≤0.06NegativeNoDC8661*E. coli*S≤0.06NegativeNoDC8663*E. coli*S0.125NegativeNoDC8664*E. coli*S2NegativeNoDC8665*E. coli*S≤0.06NegativeNoDC8666*E. coli*S0.06NegativeNoDC8667*E. coli*S≤0.06NegativeNoDC8668*E. coli*S≤0.06NegativeNoDC8669*E. coli*S≤0.06NegativeNoDC8670*E. coli*S≤0.06NegativeNoDC8671*E. coli*S≤0.06NegativeNoDC8672*E. coli*S≤0.06NegativeNoDC8673*E. coli*S≤0.06NegativeNoDC8674*E. coli*S0.06NegativeNoDC8675*E. coli*S≤0.06NegativeNoDC8676*E. coli*S≤0.06NegativeNoDC8677*E. coli*S≤0.06NegativeNoDC8678*E. coli*S≤0.06NegativeNoDC8679*E. coli*S≤0.06NegativeNoDC8680*E. coli*S0.25NegativeNoDC8681*E. coli*S2NegativeNoDC8682*E. coli*S0.125NegativeNoDC8683*E. coli*S≤0.06NegativeNoDC8684*E. coli*S≤0.06NegativeNoDC8685*E. coli*S≤0.06NegativeNoDC8686*E. coli*S0.06NegativeNoDC8687*E. coli*S0.06NegativeNoDC8688*E. coli*S0.06NegativeNoDC8690*E. coli*S0.06NegativeNoDC8691*E. coli*S0.125NegativeNo*ME* major error, *S* susceptible, *R* resistant Table 2Colistin MICs for 253 Gram-negative isolatesOrganismNumber of isolatesColistin MIC (mg/L)≤0.060.1250.250.5124816≥32Total25386562719841413521*A. baumannii*58151956414310*P. aeruginosa*61423174117013*K. pneumoniae*70306383001118*E. coli*6437821023920 Table 3Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test results among Gram-negative isolatesOrganismSusceptibility to polymyxinsResistance mechanismIsolatesRapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP testSensitivitySpecificity*A. baumannii*ResistantMediated by chromosome^a^8 (3.16%)8 positive result100%96%Susceptible50 (19.76%)48 negative results and 2 positive result*P. aeruginosa*ResistantMediated by chromosome11 (4.35%)11 positive result100%100%Susceptible50 (19.76%)50 negative results*K. pneumoniae*ResistantMediated by chromosome^a^20 (7.91%)20 positive result100%100%Susceptible50 (19.76%)50 negative results*E. coli*ResistantMediated by plasmid14 (5.54%)2 positive result100%100%Susceptible50 (19.76%)50 negative results^a^Unpublished

Discussion {#Sec3}
==========

In this study, we described the diagnostic performance of the Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test, a phenotypic method for differentiation between colistin-resistant strains and colistin-susceptible strains. Compared with the reference BMD, the Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test showed accuracy in detecting the resistance to colistin. Besides, the method was fast, easy to perform, and the obtained data were easy to interpret. Rapid Polymyxin NP test makes up for the limitations of applicability in non-fermenters \[[@CR14]\]. In our study, we examined it efficiency in detecting non-fermentative bacteria, but also fermentative bacteria, such as *E. coli* strains and *K. pneumoniae* strains. The results showed that the sensitivity and specificity of the Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test to *Enterobacteriaceae* were 100%, which was consistent with a previous study \[[@CR15]\]. In the present study, there were only two ME in colistin-susceptible *A. baumannii* strains. The categorical agreement for all tested isolates was 99.2% for the Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test. In addition, the sensitivity and specificity were respectively 100 and 99%, which further suggested that this method is suitable for detecting fermentative bacteria.

So far, a number of studies have examined the mechanism of colistin resistance \[[@CR17], [@CR18]\]. This study revealed that chromosome mutations of two-component regulatory systems (TCSs) and *mcr-1*, which were located in plasmid, were the main causes of colistin resistance in 53 strains. In addition, we were able to detect drug resistance without a difference. Therefore, compared with the Rapid Polymyxin NP test, the Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test is suitable to be used in more scenes.

MicroScan Colistin Well is a newly developed kit for detection of colistin resistance in Gram-negative bacteria \[[@CR19]\]. The fundamental principle of the Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test is similar to MicroScan Colistin Well. Both methods can be used to detect living bacteria in the medium with 4 mg/L or 3.75 mg/L of colistin (close to the breakpoint of colistin resistance). Similarly, the MICs cannot be determined utilizing the Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test and the MicroScan Colistin Well. Only colistin resistance results or sensitive test results can be obtained by them. However, there are two major differences between the two methods. First, Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test is significantly faster compared to MicroScan Colistin Well. For example, the detection of *P. aeruginosa* by Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test takes maximum 5 h to analyze the results, while MicroScan Colistin Well requires 16 to 18 h. Secondly, in the presence of resazurin reagent PrestoBlue®, the growth of living bacteria of the Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test can be more clearly observed compared to MicroScan Colistin Well.

The principle of Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test is based on the visual detection of the reduction of the resazurin reagent, a viability colorant that is observed by color change (blue to purple or pink). Interestingly, in the current study, no significant color changes were observed in colistin-resistant *P. aeruginosa* after the addition of the resazurin reagent for 1 h. After prolonging the observation time for another 1 h, the color changed from blue to purple. In other words, the results were not obtained until 2 h later in the study, while very obvious color changes were observed 15 min after the addition of the resazurin reagent in the colistin-resistant strains of *A. baumanii*, *K. pneumoniae* and *E. coli*, including 2 ME. This may be because the growth rate of *P. aeruginosa* is slower than that of *Enterobacteriaceae*, thus taking longer to decompose resazurin into fluorescent substance resorufin. It suggested that the observation time of the results of this experiment needed to be optimized according to the strain.

However, the Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test still has some limitations. Firstly, the accurate MIC values could not be obtained. Since the Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test was not suitable for the study of high-level drug resistant strains, the method could only show whether the colistin resistant was present or not. Secondly, several *mcr*-harboring isolates with an MIC of 2 mg/L (or even less) to colistin or polymyxin B have been reported \[[@CR20], [@CR21]\], while our method could only be used to screen colistin resistant strains with MIC ≥4 mg/L. Thirdly, the reading time of *P. aeruginosa* results was different from that reported by the inventors, requiring an additional 1 h of observation time.

Conclusion {#Sec4}
==========

The Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test has great stability and sensitivity in detection of colistin resistance in Gram-negative bacteria such as *A. baumanii*, *P. aeruginosa*, *K. pneumoniae* and *E. coli* strains. In addition, this method is fast and easy to perform. It can contribute in selecting more precise therapeutic choices, and optimizing antibiotic stewardship, and preventing the development of outbreaks with multidrug-resistant isolates. Nevertheless, the testing time of *P. aeruginosa* is longer than that reported by the inventor, so the observation time of this method needs to be further optimized.

Methods {#Sec5}
=======

Bacterial strains {#Sec6}
-----------------

A total of 253 nonduplicate clinical Gram-negative isolates including *A. baumanii* strains (*n* = 58), *P. aeruginosa* strains (*n* = 61), *K. pneumoniae* strains (*n* = 70) and *E. coli* strains (*n* = 64) were obtained from a teaching hospital in Wenzhou, China. Species identification was performed using the Matrix-Assisted Laser Desorption Ionization Time-Of-Flight Mass Spectrometry (MALDI-TOF MS, Bruker Daltonics, US). A total of 53 colistin-resistant strains were selected from our previous studies and were detected by BMD, including 8 *A. baumanii* strains, 11 *P. aeruginosa* strains, 20 *K. pneumoniae* strains and 14 *E. coli* strains. In addition, 50 colistin-susceptible isolates of each four bacterial species mentioned above were randomly selected as the control group. *E. coli* ATCC 25922 and *P. aeruginosa* ATCC 27853 were used as control strains \[[@CR6]\].

Antimicrobial susceptibility test {#Sec7}
---------------------------------

BMD was performed in triplicate. According to the EUCAST/CLSI joined guidelines \[[@CR6], [@CR7]\], the clinical breakpoints for colistin provided for *P. aeruginosa* and *A. baumanii* were ≤ 2 mg/L (susceptible breakpoint) and ≥ 4 mg/L (resistant breakpoint) and *Enterobacteriaceae* are ≤2 mg/L (susceptible breakpoint) and \> 2 mg/L (resistant breakpoint).

Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test {#Sec8}
---------------------------------------------------------

The experimental procedure was performed according to the previously described protocol \[[@CR15]\]. Briefly, the colistin-containing Mueller Hinton broth (MHB, OXOID, UK) solution was prepared with an initial concentration of 4.16 mg/L. Then, a 180 μl colistin-free MHB solution and colistin-containing MHB solution were added to lines A and B of a 96-well polystyrene micro test plate, respectively. For each isolate, 20 μl of the bacterial suspension at a 3.5 McFarland optical density (\~ 1 × 10^9^ CFU/mL) was inoculated in parallel into two wells, with and without colistin. The bacterial suspension was mixed with the medium by pipetting up and down. The final concentration of colistin was 3.75 mg/L. In the same way, 20 μl of 0.85% NaCl was used as an aseptic control, 20 μl of the colistin-susceptible isolate (*E. coli* ATCC 25922 and *P. aeruginosa* ATCC 27853) suspension was used as negative control; and 20 μl of the colistin-resistant isolate (the clinical isolates of Morgan, inherent resistance to polymyxin) suspension was used as a positive control. After testing several isolates, we ensured that the color-transfer of colistin suspension and the mixing of bacterial suspension in the micro test plate were completed within 15 min. The inoculated tray was incubated at 35 ± 2 °C for 3 h. Then, 22 μl of the resazurin reagent PrestoBlue® (ThermoFisher Scientific, US, final concentration is 10% V/V) was added per well and each well was mixed by pipetting up and down. Finally, the tray was visually inspected every 15 min within 1 h. Susceptibility of colistin is determined by the color changes, where discoloration indicates that the strain is colistin-resistant, while the lack of discoloration indicates that the strain is colistin-susceptible \[[@CR15]\]. All experiments were performed in triplicate.

The test was considered to be positive (i.e., purple or pink) if the colistin-resistant isolate was viable in presence of colistin, or negative (i.e., blue) if the colistin-susceptible isolate was not viable in presence of colistin. The Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test interpretation is illustrated in Fig. [1](#Fig1){ref-type="fig"}. Fig. 1Representative results of the Rapid ResaPolymyxin *Acinetobacter*/*Pseudomonas* NP test. Non-inoculated well is shown as the control of the medium and the color changed (first column). Negative, the tested isolate only grows in the absence of colistin (second column). Positive, the tested isolate grows in the presence and absence of colistin (third column)
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